DaCosta and Minden Labs Awarded CIHR Grant
https://dacostalab.ca/wp-content/uploads/2020/09/cihr-logo-1030x576.jpg 1030 576 DaCosta Lab DaCosta Lab https://dacostalab.ca/wp-content/uploads/2020/09/cihr-logo-1030x576.jpgDrs. Ralph DaCosta and Mark Minden have been awarded a 4-year CIHR Project Grant to identify new treatment options for acute myeloid leukemia (AML). AML is a disease of the bone marrow (BM) that spreads throughout the bones of affected patients. Interactions between AML cells and its surroundings play important protective and promotive functions in leukemia growth, maintenance, and spread. Current laboratory experimental systems are not yet able to recapitulate this dynamic relationship outside of the body, and animal studies cannot visualize the changes in AML progression until death of the animal. Such methodologies are blind to important aspects…
read more